Galapagos NV has discovered a new class of antibiotics and has selected a candidate drug, CAM-1, that shows strong activity against all tested drug resistant Staphylococcus aureus, including hospital and community acquired MRSA strains. MRSA is a potentially life-threatening infection that occurs most frequently among patients in hospitals.   This antibiotic works by inhibiting the target DNA pol III alpha, an enzyme present in all bacteria and essential for their growth; this target is absent i...